ACADIAN ASSET MANAGEMENT LLC - BIOSTAR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of BIOSTAR PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$239,000
-27.8%
107,196
+5.9%
0.00%0.0%
Q1 2018$331,000
+1082.1%
101,195
+550.1%
0.00%
Q4 2017$28,000
+154.5%
15,567
+74.9%
0.00%
Q3 2017$11,000
-38.9%
8,898
-22.4%
0.00%
Q2 2017$18,0000.0%11,464
+44.8%
0.00%
Q1 2017$18,000
+50.0%
7,916
+88.6%
0.00%
Q4 2016$12,000
-25.0%
4,1970.0%0.00%
Q3 2016$16,0004,1970.00%
Other shareholders
BIOSTAR PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 2,000$9,0000.01%
Renaissance Technologies 105,956$468,0000.00%
UBS Group AG 4,793$21,0000.00%
BANK OF AMERICA CORP /DE/ 143$1,0000.00%
DEUTSCHE BANK AG\ 2$00.00%
CREDIT SUISSE AG/ 29,116$129,0000.00%
MORGAN STANLEY 24$00.00%
JANE STREET GROUP, LLC 15,556$69,0000.00%
View complete list of BIOSTAR PHARMACEUTICALS INC shareholders